Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Carcinoma, Non-Small-Cell Lung 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Nasopharyngeal Carcinoma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Carcinoma, Squamous Cell 1

Interventions

Doxorubicin 8Vincristine 7Prednisone 7Cyclophosphamide 7Rituximab 5VAP-cyclo protocol 3Radiotherapy 3Methotrexate 3Filgrastim 3Cytarabine 3liposomal amphotericin B 2Vinblastine 2Levofloxacin 2Leucovorin 2Hydrocortisone 2Etoposide 2Early Intervention, Educational 2Drug Therapy 2Dexamethasone 2Darbepoetin alfa 2liposomal doxorubicin 1ferrous sulfate 1ferric gluconate 1belinostat 1Sucrose 1Steroids 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Psychiatric Rehabilitation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large-Cell, Anaplastic × Maintenance × Clear all
NCT04881838 2026-03-19

CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL

Children's Cancer Group, China

Phase 3 Active not recruiting
172 enrolled
Lymphoid

Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡